FDA Warning Letter — Medivera Compounding Pharmacy

Case 470499 — FEI 3011130315

The FDA took a Warning Letter action against Medivera Compounding Pharmacy on February 26, 2016 (Troy, MI). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Medivera Compounding Pharmacy
Date
February 26, 2016
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Troy, MI (United States)